408 related articles for article (PubMed ID: 28181469)
1. Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy.
Han B; Du Y; Fu T; Fan Z; Xu S; Hu C; Bi L; Gao T; Zhang H; Xu W
Appl Spectrosc; 2017 Feb; 71(2):300-307. PubMed ID: 28181469
[TBL] [Abstract][Full Text] [Related]
2. The use of Au@SiO2 shell-isolated nanoparticle-enhanced Raman spectroscopy for human breast cancer detection.
Zheng C; Liang L; Xu S; Zhang H; Hu C; Bi L; Fan Z; Han B; Xu W
Anal Bioanal Chem; 2014 Sep; 406(22):5425-32. PubMed ID: 24958347
[TBL] [Abstract][Full Text] [Related]
3. p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women.
Mao XY; Fan CF; Zheng HC; Wei J; Yao F; Jin F
J Exp Clin Cancer Res; 2010 Aug; 29(1):112. PubMed ID: 20712900
[TBL] [Abstract][Full Text] [Related]
4. [Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast].
Zhang JL; Zhang HY; Wei B; Lang ZQ; Bu H
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):316-9. PubMed ID: 15363314
[TBL] [Abstract][Full Text] [Related]
5. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
6. Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In Situ.
Tozbikian G; Brogi E; Vallejo CE; Giri D; Murray M; Catalano J; Olcese C; Van Zee KJ; Wen HY
Int J Surg Pathol; 2017 Apr; 25(2):100-107. PubMed ID: 27481892
[TBL] [Abstract][Full Text] [Related]
7. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Pinder SE; Ellis IO
Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
[TBL] [Abstract][Full Text] [Related]
9. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
10. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.
Gobbi H; Jensen RA; Simpson JF; Olson SJ; Page DL
Hum Pathol; 2001 Aug; 32(8):785-90. PubMed ID: 11521220
[TBL] [Abstract][Full Text] [Related]
11. [Changes of fibroblast immunophenotype and their clinical significance in stromal remodeling of breast tumors].
Hua X; Huang X; Liao Z; Xian Q; Yu L
Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):834-8. PubMed ID: 25620480
[TBL] [Abstract][Full Text] [Related]
12. Mammotome core biopsy for mammary microcalcification: analysis of 160 biopsies from 142 women with surgical and radiologic followup.
Cangiarella J; Waisman J; Symmans WF; Gross J; Cohen JM; Wu H; Axelrod D
Cancer; 2001 Jan; 91(1):173-7. PubMed ID: 11148574
[TBL] [Abstract][Full Text] [Related]
13. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
14. bcl-2 expression in the spectrum of preinvasive breast lesions.
Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
[TBL] [Abstract][Full Text] [Related]
15. US-guided 14G core needle biopsy: comparison between underestimated and correctly diagnosed breast cancers.
Kim H; Youk JH; Kim JA; Gweon HM; Jung WH; Son EJ
Asian Pac J Cancer Prev; 2014; 15(7):3179-83. PubMed ID: 24815467
[TBL] [Abstract][Full Text] [Related]
16. HER2 as a prognostic factor in breast cancer.
Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
[TBL] [Abstract][Full Text] [Related]
17. 14-3-3ζ promoted invasion and lymph node metastasis of breast invasive ductal carcinoma with HER2 overexpression.
Wan D; Zhang Y; Yu Q; Li F; Zhuo J
Pathol Res Pract; 2021 Nov; 227():153619. PubMed ID: 34560418
[TBL] [Abstract][Full Text] [Related]
18. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively.
Vandenbussche CJ; Khouri N; Sbaity E; Tsangaris TN; Vang R; Tatsas A; Cimino-Mathews A; Argani P
Am J Surg Pathol; 2013 Jun; 37(6):913-23. PubMed ID: 23598968
[TBL] [Abstract][Full Text] [Related]
19. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
20. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
Pawloski KR; Christian N; Knezevic A; Wen HY; Van Zee KJ; Morrow M; Tadros AB
Breast Cancer Res Treat; 2020 Dec; 184(3):873-880. PubMed ID: 32857242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
